Abstract
Published guidelines adopted in many countries recommend that women whose family history of breast cancer places them at a risk ≥1.7 times that of the age-matched general population, should be considered for inclusion in special surveillance programmes. However validation of risk assessment models has been called for as a matter of urgency. The databases of the four Scottish Familial Breast Cancer clinics and the Scottish Cancer Registry have been searched to identify breast cancers occurring among 1,125 women aged 40–56, with family histories placing them below the “moderate” level of genetic risk. The observed incidence over 6 years was compared with age-specific data for the Scottish population. Our findings confirm that when there are two affected relatives (one first degree) the relative risk (RR) exceeds 1.7 regardless of their ages at diagnosis. When only one (first degree) relative was affected at any age from 40 to 55, the RR does not reach 1.7 if that relative was a mother but exceeds it if the relative was a sister. The probable explanation is that sisters are more likely than mother/daughter pairs to share homozygosity for a risk allele. Surveillance programmes might therefore accommodate sisters of women affected before age 55. Evidence that “low penetrance” alleles contributing to breast cancer risk may be recessive should be taken into account in strategies for identifying them.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amir A, Evans DG, Shenton A, Lalloo F, Moran B, Boggis C et al (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807–814. doi:10.1136/jmg.40.11.807
Anderson E, Berg J, Black R, Bradshaw N, Campbell J, Carnaghan H et al (2008) Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold. Br J Cancer 98:840–844
Antoniou AC, Pharoah PDP, McMullan G, Day NE, Ponder BAJ, Easton D (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21:1–18. doi:10.1002/gepi.1014
Brennan P, Shaw T, Claber O (2007) The Teeside cancer family history service: change management and innovation at cancer network level. Fam Cancer 6:181–187. doi:10.1007/s10689-007-9125-0
Campbell H, Holloway S, Cetnarskyj R, Anderson E et al (2003) Referral of patients with a family history of breast cancer from primary care to cancer genetics services in SE Scotland. Br J Cancer 89:1650–1656. doi:10.1038/sj.bjc.6601348
Colditz GA, Willett WC, Hunter DJ, Stampfer MJ, Manson JE, Hennekens CH et al (1993) Family history, age and risk of breast cancer. Prospective data from the nurses’ health study. JAMA 270:338–343. doi:10.1001/jama.270.3.338
Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet 358:1389–1399. doi:10.1016/S0140-6736(01)06524-2
Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF et al (2001) After BRCA1 and BRCA2—what next? Multifactorial segregation analysis of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet 68:420–431. doi:10.1086/318187
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, SEARCH collaborators, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey S, Shen CY, Wu PE, Wang HC, Eccles DE, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevallina H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Schurmann P, Dork T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock JW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Utterlinden A, Rivadeneira F, Milne RL, Ribas G, Gonzales-Neira A, Benitez J, Hopper JL, McCredie M, Southey M, GilesGG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X, kConFab AOCS Managemnt Group, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087–1093. doi:10.1038/nature05887
Eccles DM, Evans DG, Mackay J, UK Cancer Family History Study group (2000) Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. J Med Genet 37:203–209. doi:10.1136/jmg.37.3.203
Haites NE, Hodgson SV the Scottish Working group on Cancer Genetics (2002) Guidelines for development of cancer genetics services. In: Morrison PJ, Hodgson SV, Haites NE (eds) Familial breast and ovarian cancer: genetics, screening and management, chap 11. Cambridge University Press, pp 166–193
Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870–874. doi:10.1038/ng2075
National Institute for Clinical Excellence (NICE) (2004, updated 2006). Familial breast cancer. The classification of women at risk of familial breast cancer in primary, secondary and tertiary care. Clinical Guideline 14. London
Nelson HD, Huffman LH, Fu R, Harris EL, US Preventive Services Task Force (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US Preventive services Task Force. Ann Intern Med 143:362–379
Pharoah PDP, Day NE, Duffy S, Easton DF, Ponder BAJ (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:900–809. doi:10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B
Pharoah PDP, Lipscombe JM, Redman KL, Day NE, Easton DF, Ponder BAJ (2000) Familial predisposition to breast cancer in a British population: implications for prevention. Eur J Cancer 36:773–779. doi:10.1016/S0959-8049(00)00023-X
Ponder BA (2004) Cancer genetics. Nature 411:336–341 (review). doi:10.1038/35077207
Reis MM, Young D, McLeish L, Goudie D, Cook A, Sullivan F et al (2006) Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations. Fam Cancer 5:297–303. doi:10.1007/s10689-006-7849-x
Scottish Intercollegiate Guidelines Network (SIGN). Guideline 29 (1998) Breast cancer in women. Edinburgh
Steel CM (2007) Cancer of the breast and female reproductive tract. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR (eds) Emery and Rimoin’s principles and practice of medical genetics, chap 93, 5th edn. Churchill Livingstone, Philadelphia, pp 2093–2121
Acknowledgement
This study was supported by funds from the Scottish Executive Health Department.
Author information
Authors and Affiliations
Corresponding author
Additional information
All the authors are from the Scottish Cancer Family Clinical Centres.
Rights and permissions
About this article
Cite this article
Anderson, E., Berg, J., Black, R. et al. Predicting breast cancer risk: implications of a “weak” family history. Familial Cancer 7, 361–366 (2008). https://doi.org/10.1007/s10689-008-9197-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-008-9197-5